Skip to content

Linde reveals its financial outcomes for the second quarter of 2025

Linde PLC reports Q2 2025 earnings of $1.766 billion, equivalent to $2.97 per share, as announced today.

Linde releases second-quarter financial results for the year 2025
Linde releases second-quarter financial results for the year 2025

Linde reveals its financial outcomes for the second quarter of 2025

Linde plc, a leading global industrial gases and engineering company, reported strong financial results for the second quarter of 2025. The company's sales, operating profit, and earnings per share (EPS) all saw growth compared to the prior year.

Sales for the quarter were $8.495 billion, a 3% year-over-year (YoY) increase. Operating profit reached approximately $2.4 billion, up 6% YoY. Adjusted earnings per share (EPS) were $4.09, marking a 6% YoY increase, while GAAP diluted EPS was $3.73, up 8% YoY. The operating profit margin improved by 80 basis points to about 27.7% (adjusted margin at 30.1%). Operating cash flow reached $2.211 billion, increasing 15% YoY [1][2][3][4].

Return to Shareholders

The company returned $1,811 million to shareholders through dividends and stock repurchases in the second quarter.

Guidance for Full-Year 2025

Regarding guidance, Linde expects full-year 2025 adjusted EPS in the range of $16.30 to $16.50, representing 5-6% growth YoY. This outlook is supported by a record project backlog and strong cash flow [2][4].

Key Highlights

  • Sales: $8.495 billion (+3% YoY)
  • Operating profit: ~$2.4 billion (+6% YoY)
  • Operating margin: 27.7% (adjusted 30.1%)
  • EPS (adjusted): $4.09 (+6% YoY)
  • GAAP EPS: $3.73 (+8% YoY)
  • Operating cash flow: $2.211 billion (+15% YoY)
  • Full-year 2025 adjusted EPS guidance: $16.30–$16.50 (+5-6% YoY)

These results reflect strong pricing power, effective cost management, and robust operational execution despite regional volume softness in EMEA and APAC [1][3].

The attachments include a summary of non-GAAP reconciliations, statements of income, balance sheets, statements of cash flows, segment information, and appendix: non-GAAP measures and reconciliations. The materials for the teleconference are available on the company's website.

The live webcast (listen-only) is available at https://www.linde.com/investors/financial-reports. The live conference call can be accessed using the US Toll-Free Dial-In Number: 1 888 770 7292 or the UK Toll-Free Dial-In Number: 0800 358 0970 with access code: 6877110.

Linde plc assumes no obligation to update or provide revisions to any forward-looking statement in response to changing circumstances. The company provides forward-looking statements, which are identified by terms and phrases such as: anticipate, believe, intend, estimate, expect, continue, should, could, may, plan, project, predict, will, potential, forecast, and similar expressions.

The above-listed risks and uncertainties are further described in Item 1A. Risk Factors in Linde plc's Form 10-K for the fiscal year ended December 31, 2024 filed with the SEC on February 26, 2025.

Linde plc serves various end markets such as chemicals & energy, food & beverage, electronics, healthcare, manufacturing, metals and mining. The company's products and services include production of clean hydrogen and carbon capture systems, life-saving medical oxygen, high-purity & specialty gases for electronics, and gas processing solutions.

For media inquiries, contact Anna Davies, Director of External Communications at Linde plc. Contact information is provided in the attachments.

[1] Linde plc, Q2 2025 Financial Results Press Release, 2025. [2] Linde plc, Q2 2025 Earnings Presentation, 2025. [3] Linde plc, Q2 2025 Earnings Call Transcript, 2025. [4] Linde plc, Q2 2025 Form 6-K, 2025.

The strong financial performance of Linde plc, as reported in the Q2 2025 results, has opened up opportunities for increased investments in various sectors such as finance and business. The company's robust operational execution and effective cost management have bolstered its cloud security, ensuring secure transactions and data storage for its clients in the electronics and healthcare industries. With the company's guidance for full-year 2025 adjusted EPS in the range of $16.30 to $16.50, representing 5-6% growth YoY, investors can anticipate ongoing growth and potential returns through dividends and stock repurchases.

Read also:

    Latest